ANNX
Annexon, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C
Company Profile
CEO
Douglas E. Love
IPO Date
2020-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Annexon, Inc.
CEO
Douglas E. Love
IPO Date
2020-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 8,000 |
| $5.78 |
| 14 Apr 2026 | Carson William H. | director | P-Purchase | Acquired | 8,000 | $6.20 |
| 12 Mar 2026 | Carson William H. | director | P-Purchase | Acquired | 8,000 | $5.67 |
| 4 Mar 2026 | Dananberg Jamie | CHIEF MEDICAL OFFICER | S-Sale | Disposed | 5,820 | $5.43 |
| 4 Mar 2026 | Overdorf Michael | EVP & CHIEF BUSINESS OFFICER | S-Sale | Disposed | 4,339 | $5.42 |
| 4 Mar 2026 | Yednock Ted | EVP & CHIEF INNOVATION OFFICER | S-Sale | Disposed | 5,566 | $5.42 |
| 4 Mar 2026 | ARTIS DEAN RICHARD | EVP & CHIEF SCIENTIFIC OFFICER | S-Sale | Disposed | 5,894 | $5.43 |
| 4 Mar 2026 | Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | S-Sale | Disposed | 5,565 | $5.42 |
| 23 Feb 2026 | Love Douglas | director, officer: PRESIDENT AND CEO | A-Award | Acquired | 1,250,000 | $5.10 |